Vaccine take was defined as seroconversion ( a 3-fold increase in serum anti-rotavirus IgA or serum neutralising antibody ( SNA ) from baseline at day 28 post-dose ) or evidence of RV3-BB viral replication in the faeces by RT-PCR analysis 3-6 days post-vaccination .
